Trial Profile
What is the optimal amplitude for a square wave bolus of insulin aspart in children and young people aged 7-35years to control postprandial hyperglycaemia (postprandial blood glucose excursion at 1 hour <3mmol/L)?
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk Pharmaceuticals
- 19 Jun 2012 New trial record